Healio

FDA approves Johnson & Johnson’s Tecnis PureSee IOL

The FDA approved the Tecnis PureSee IOL, an extended depth of focus IOL for cataract surgery, according to a press release from Johnson & Johnson.
Healio

Refractive IOL surgery: Closing in on a zero enhancement rate

My New York City practice has been a refractive-only practice for more than 25 years, offering the full range of FDA-approved ...
Medical Device and Diagnostic Industry (MD+DI)

FDA Approves Johnson & Johnson's Breakthrough Cataracts Solution

The Tecnis PureSee IOL is the first FDA-approved extended depth of focus IOL maintaining contrast sensitivity comparable to an aspheric monofocal IOL.

The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence.

The TECNIS Odyssey IOL addresses a significant unmet need for cataract patients seeking greater spectacle independence., Bizz ...
Becker's ASC

17 Facts and Business and Legal Issues About Premium Intraocular Lenses for Cataract Patients

Here are 17 facts and business and legal issues about premium intraocular lenses, a recent technology that can free many cataract surgery patients from having to wear eyeglasses. 1. In one of the few ...
Seeking Alpha

Alcon Surpasses 175 Million IOLs Implanted Globally

GENEVA--(BUSINESS WIRE)-- Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announced that more than 175 million of its intraocular lenses (IOLs) have ...
Ophthalmology Times

FDA approves Johnson & Johnson's TECNIS PureSee EDOF IOL

FDA approval supports US commercialization of TECNIS PureSee, an EDOF IOL for implantation during cataract surgery, with availability anticipated later in 2026. PureSee is positioned to preserve ...